Duopharma Biotech Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	931.69	813.7	704.73	696.72	639.18
Revenue Growth (YoY)	14.50%	15.46%	1.15%	9.00%	12.16%
Cost of Revenue	568.56	512.16	436.4	416.9	385.19
Gross Profit	363.14	301.54	268.33	279.82	253.98
Selling, General & Admin	227.58	202.02	182.72	186.59	165.78
Other Operating Expenses	1.77	0.7	2.8	0.81	-0.67
Operating Expenses	229.35	201.28	189.61	186.91	165.22
Operating Income	133.79	100.26	78.71	92.91	88.77
Interest Expense	-24.75	-25.77	-17.68	-9.1	-6.44
Interest & Investment Income	5.87	5.97	2.75	1.52	1.2
Other Non Operating Income (Expenses)	-	-0.82	-0.52	-0.48	-0.53
EBT Excluding Unusual Items	114.91	79.63	63.27	84.85	82.99
Gain (Loss) on Sale of Assets	-	0.39	-	-	-0.01
Pretax Income	114.91	80.02	63.27	84.85	82.98
Income Tax Expense	27.45	17.38	10.62	14.74	17.3
Net Income	87.46	62.65	52.65	70.11	65.68
Net Income to Common	87.46	62.65	52.65	70.11	65.68
Net Income Growth	39.62%	19.00%	-24.91%	6.74%	12.07%
Shares Outstanding (Basic)	962	962	959	948	928
Shares Outstanding (Diluted)	962	962	959	948	928
Shares Change (YoY)	-	0.36%	1.08%	2.15%	0.02%
EPS (Basic)	0.09	0.07	0.05	0.07	0.07
EPS (Diluted)	0.09	0.07	0.05	0.07	0.07
EPS Growth	39.58%	18.57%	-25.71%	4.50%	12.05%
Free Cash Flow	80.08	59.77	15.86	5.08	-66.16
Free Cash Flow Per Share	0.08	0.06	0.02	0.01	-0.07
Dividend Per Share	0.045	0.030	0.023	0.023	0.022
Dividend Growth	51.67%	30.44%	-	5.75%	-55.43%
Gross Margin	38.98%	37.06%	38.07%	40.16%	39.74%
Operating Margin	14.36%	12.32%	11.17%	13.33%	13.89%
Profit Margin	9.39%	7.70%	7.47%	10.06%	10.28%
Free Cash Flow Margin	8.60%	7.35%	2.25%	0.73%	-10.35%
EBITDA	179.41	137.34	114.04	122.86	114.94
EBITDA Margin	19.26%	16.88%	16.18%	17.63%	17.98%
D&A For EBITDA	45.62	37.08	35.32	29.95	26.18
EBIT	133.79	100.26	78.71	92.91	88.77
EBIT Margin	14.36%	12.32%	11.17%	13.33%	13.89%
Effective Tax Rate	23.89%	21.72%	16.79%	17.37%	20.85%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.